维普中文期刊产品整合服务
1篇 您的检索式:作者名="F.Fondelli"
    题名 作者 年代 出处 被引量
1Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy显示文摘Multiple sclerosis(MS)is a leading cause of chronic neurological disability in young to middle-aged adults,affecting~2.5 million people worldwide.Currently,most therapeutics for MS are systemic immunosuppressive or immunomodulatory drugs,but these drugs are unable to halt or reverse the disease and have the potential to cause serious adverse events.Hence,there is an urgent need for the development of next-generation treatments that,alone or in combination,stop the undesired autoimmune response and contribute to the restoration of homeostasis.This review analyzes current MS treatments as well as different cell-based therapies that have been proposed to restore homeostasis in MS patients(tolerogenic dendritic cells,regulatory T cells,mesenchymal stem cells,and vaccination with T cells).Data collected from preclinical studies performed in the experimental autoimmune encephalomyelitis(EAE)model of MS in animals,in vitro cultures of cells from MS patients and the initial results of phase I/II clinical trials are analyzed to better understand which parameters are relevant for obtaining an efficient cell-based therapy for MS.M.J.Mansilla S.Presas-Rodríguez A.Teniente-Serra I.González-Larreategui B.Quirant-Sánchez F.Fondelli N.Djedovic D.Iwaszkiewicz-Grześ K.Chwojnicki D.Miljković PTrzonkowski C.Ramo-Tello E.M.Martínez-Cáceres 2021Cellular & Molecular Immunology2021,18,6:2
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费